NO20052733D0 - C-6 modifiserte indazolylpyrrolotriaziner - Google Patents

C-6 modifiserte indazolylpyrrolotriaziner

Info

Publication number: NO20052733D0
Authority: NO; Norway
Prior art keywords: indazolylpyrrolotriazines; modified; modified indazolylpyrrolotriazines
Prior art date: 2002-12-13

Application number

NO20052733A

Other languages

English (en)

Other versions

NO20052733L (no

Inventor

Gregory D Vite

John F Kadow

Ashvinikumar Gavai

Harold Mastalerz

Brian E Fink

Original Assignee

Bristol Myers Squibb Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-12-13

Filing date

2005-06-07

Publication date

2005-06-07

2005-06-07 Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co

2005-06-07 Publication of NO20052733D0 publication Critical patent/NO20052733D0/no

2005-07-07 Publication of NO20052733L publication Critical patent/NO20052733L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Physical Education & Sports Medicine (AREA)
Immunology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Orthopedic Medicine & Surgery (AREA)
Dermatology (AREA)
Urology & Nephrology (AREA)
Biomedical Technology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Inks, Pencil-Leads, Or Crayons (AREA)

NO20052733A 2002-12-13 2005-06-07 C-6 modifiserte indazolylpyrrolotriaziner NO20052733L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US43319002P	2002-12-13	2002-12-13
PCT/US2003/039542 WO2004054514A2 (en)	2002-12-13	2003-12-12	C-6 modified indazolylpyrrolotriazines

Publications (2)

Publication Number	Publication Date
NO20052733D0 true NO20052733D0 (no)	2005-06-07
NO20052733L NO20052733L (no)	2005-07-07

Family

ID=32595133

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20052733A NO20052733L (no)	2002-12-13	2005-06-07	C-6 modifiserte indazolylpyrrolotriaziner

Country Status (27)

Country	Link
US (2)	US6916815B2 (no)
EP (1)	EP1569937B1 (no)
JP (1)	JP4511367B2 (no)
KR (1)	KR101073801B1 (no)
CN (2)	CN1726216A (no)
AR (1)	AR042450A1 (no)
AT (1)	ATE534648T1 (no)
AU (1)	AU2003300877B2 (no)
BR (1)	BR0316755A (no)
CA (1)	CA2509650C (no)
CO (1)	CO5570660A2 (no)
DK (1)	DK1569937T3 (no)
ES (1)	ES2374393T3 (no)
HR (1)	HRP20050535A2 (no)
IS (1)	IS7890A (no)
MX (1)	MXPA05006164A (no)
NO (1)	NO20052733L (no)
NZ (1)	NZ540338A (no)
PE (1)	PE20040805A1 (no)
PL (1)	PL377517A1 (no)
PT (1)	PT1569937E (no)
RS (1)	RS20050441A (no)
RU (1)	RU2356903C2 (no)
TW (1)	TW200420565A (no)
UA (1)	UA80591C2 (no)
WO (1)	WO2004054514A2 (no)
ZA (1)	ZA200504507B (no)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2273083C (en) *	1996-12-03	2012-09-18	Sloan-Kettering Institute For Cancer Research	Synthesis of epothilones, intermediates thereto, analogues and uses thereof
US7393823B1 (en)	1999-01-20	2008-07-01	Oregon Health And Science University	HER-2 binding antagonists
US7625859B1 (en)	2000-02-16	2009-12-01	Oregon Health & Science University	HER-2 binding antagonists
US6867300B2 (en)	2000-11-17	2005-03-15	Bristol-Myers Squibb Company	Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors
US20090197852A9 (en) *	2001-08-06	2009-08-06	Johnson Robert G Jr	Method of treating breast cancer using 17-AAG or 17-AG or a prodrug of either in combination with a HER2 inhibitor
AU2003231034B2 (en)	2002-04-23	2009-03-05	Bristol-Myers Squibb Company	Pyrrolo-triazine aniline compounds useful as kinase inhibitors
TW200306841A (en)	2002-04-23	2003-12-01	Bristol Myers Squibb Co	Aryl ketone pyrrolo-triazine compounds useful as kinase inhibitors
TWI329112B (en) *	2002-07-19	2010-08-21	Bristol Myers Squibb Co	Novel inhibitors of kinases
US6921769B2 (en)	2002-08-23	2005-07-26	Sloan-Kettering Institute For Cancer Research	Synthesis of epothilones, intermediates thereto and analogues thereof
US7649006B2 (en)	2002-08-23	2010-01-19	Sloan-Kettering Institute For Cancer Research	Synthesis of epothilones, intermediates thereto and analogues thereof
PT1506203E (pt)	2002-08-23	2007-04-30	Sloan Kettering Inst Cancer	Síntese de epotilonas, seus intermediários, seus análogos e suas utilizações
TW200420565A (en) *	2002-12-13	2004-10-16	Bristol Myers Squibb Co	C-6 modified indazolylpyrrolotriazines
JP2006516653A (ja)	2003-02-05	2006-07-06	ブリストル−マイヤーズ　スクイブ　カンパニー	キナーゼ阻害剤ピロロトリアジンの製造方法
ES2428358T3 (es) *	2003-10-17	2013-11-07	Novo Nordisk A/S	Terapia de combinación
US7102001B2 (en) *	2003-12-12	2006-09-05	Bristol-Myers Squibb Company	Process for preparing pyrrolotriazine
US20060014741A1 (en) *	2003-12-12	2006-01-19	Dimarco John D	Synthetic process, and crystalline forms of a pyrrolotriazine compound
MY145634A (en)	2003-12-29	2012-03-15	Bristol Myers Squibb Co	Pyrrolotriazine compounds as kinase inhibitors
US7064203B2 (en) *	2003-12-29	2006-06-20	Bristol Myers Squibb Company	Di-substituted pyrrolotriazine compounds
US7459562B2 (en)	2004-04-23	2008-12-02	Bristol-Myers Squibb Company	Monocyclic heterocycles as kinase inhibitors
TW200538453A (en)	2004-04-26	2005-12-01	Bristol Myers Squibb Co	Bicyclic heterocycles as kinase inhibitors
US7102002B2 (en) *	2004-06-16	2006-09-05	Bristol-Myers Squibb Company	Pyrrolotriazine kinase inhibitors
US20050288290A1 (en)	2004-06-28	2005-12-29	Borzilleri Robert M	Fused heterocyclic kinase inhibitors
US7432373B2 (en)	2004-06-28	2008-10-07	Bristol-Meyers Squibb Company	Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors
US7439246B2 (en)	2004-06-28	2008-10-21	Bristol-Myers Squibb Company	Fused heterocyclic kinase inhibitors
TW200600513A (en) *	2004-06-30	2006-01-01	Bristol Myers Squibb Co	A method for preparing pyrrolotriazine compounds
US7253167B2 (en) *	2004-06-30	2007-08-07	Bristol-Myers Squibb Company	Tricyclic-heteroaryl compounds useful as kinase inhibitors
US7102003B2 (en) *	2004-07-01	2006-09-05	Bristol-Myers Squibb Company	Pyrrolotriazine compounds
US7504521B2 (en)	2004-08-05	2009-03-17	Bristol-Myers Squibb Co.	Methods for the preparation of pyrrolotriazine compounds
PE20060421A1 (es)	2004-08-12	2006-06-01	Bristol Myers Squibb Co	Procedimiento para preparar un compuesto de pirrolotriazina anilina como inhibidores de cinasa
CA2583230A1 (en) *	2004-10-05	2006-04-20	Oregon Health And Science University	Compositions and methods for treating disease
US7151176B2 (en) *	2004-10-21	2006-12-19	Bristol-Myers Squibb Company	Pyrrolotriazine compounds
WO2006111524A2 (en) *	2005-04-18	2006-10-26	Novo Nordisk A/S	Il-21 variants
US7405213B2 (en) *	2005-07-01	2008-07-29	Bristol-Myers Squibb Company	Pyrrolotriazine compounds useful as kinase inhibitors and methods of treating kinase-associated conditions therewith
US7402582B2 (en) *	2005-07-01	2008-07-22	Bristol-Myers Squibb Company	Pyrrolotriazine compounds useful as kinase inhibitors and methods of treating kinase-associated conditions therewith
US7880004B2 (en)	2005-09-15	2011-02-01	Bristol-Myers Squibb Company	Met kinase inhibitors
US7547782B2 (en)	2005-09-30	2009-06-16	Bristol-Myers Squibb Company	Met kinase inhibitors
US7514435B2 (en) *	2005-11-18	2009-04-07	Bristol-Myers Squibb Company	Pyrrolotriazine kinase inhibitors
US7348325B2 (en)	2005-11-30	2008-03-25	Bristol-Myers Squibb Company	Pyrrolotriazine kinase inhibitors
US8063208B2 (en)	2006-02-16	2011-11-22	Bristol-Myers Squibb Company	Crystalline forms of (3R,4R)-4-amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol
KR20080107408A (ko)	2006-03-07	2008-12-10	브리스톨-마이어스 스큅 컴퍼니	키나제 억제제로서 유용한 피롤로트리아진 아닐린 전구약물화합물
EP2091968A2 (en)	2006-10-26	2009-08-26	Novo Nordisk A/S	Il-21 variants
JP2010512769A (ja) *	2006-12-21	2010-04-30	ノヴォノルディスクアクティーゼルスカブ	Ｉｌ−２１受容体との結合が変化したインターロイキン−２１変異体
US20090083483A1 (en) *	2007-09-24	2009-03-26	International Business Machines Corporation	Power Conservation In A RAID Array
US8166326B2 (en) *	2007-11-08	2012-04-24	International Business Machines Corporation	Managing power consumption in a computer
US20090132842A1 (en) *	2007-11-15	2009-05-21	International Business Machines Corporation	Managing Computer Power Consumption In A Computer Equipment Rack
US8041521B2 (en) *	2007-11-28	2011-10-18	International Business Machines Corporation	Estimating power consumption of computing components configured in a computing system
WO2009137201A1 (en)	2008-04-04	2009-11-12	Cv Therapeutics, Inc.	Triazolopyridinone derivatives for use as stearoyl coa desaturase inhibitors
WO2009124259A1 (en) *	2008-04-04	2009-10-08	Cv Therapeutics, Inc.	Pyrrolotriazinone derivatives for use as stearoyl coa desaturase inhibitors
US20110086850A1 (en) *	2008-04-11	2011-04-14	Board Of Regents, The University Of Texas System	Radiosensitization of tumors with indazolpyrrolotriazines for radiotherapy
US8103884B2 (en)	2008-06-25	2012-01-24	International Business Machines Corporation	Managing power consumption of a computer
US8041976B2 (en) *	2008-10-01	2011-10-18	International Business Machines Corporation	Power management for clusters of computers
US8514215B2 (en) *	2008-11-12	2013-08-20	International Business Machines Corporation	Dynamically managing power consumption of a computer with graphics adapter configurations
WO2010071885A1 (en)	2008-12-19	2010-06-24	Cephalon, Inc.	Pyrrolotriazines as alk and jak2 inhibitors
MX2011009413A (es) *	2009-03-11	2011-10-21	Ambit Biosciences Corp	Combinacion de una indazolilaminopirrolotriazina y taxano para tratamiento contra cancer.
WO2011112689A2 (en) *	2010-03-11	2011-09-15	Ambit Biosciences Corp.	Saltz of an indazolylpyrrolotriazine
US9724352B2 (en)	2012-05-31	2017-08-08	Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences	Pyrrolo[2,1-F[1,2,4]triazine compounds, preparation methods and applications thereof
CN103450204B (zh)	2012-05-31	2016-08-17	中国科学院上海药物研究所	吡咯[2，1-f][1，2，4]并三嗪类化合物，其制备方法及用途
JP6386527B2 (ja) *	2013-03-11	2018-09-05	ブリストル−マイヤーズスクイブカンパニーＢｒｉｓｔｏｌ−ＭｙｅｒｓＳｑｕｉｂｂＣｏｍｐａｎｙ	カリウムイオンチャネル阻害剤としてのピロロピリダジン
US9050345B2 (en) *	2013-03-11	2015-06-09	Bristol-Myers Squibb Company	Pyrrolotriazines as potassium ion channel inhibitors
CN105026399B (zh) *	2013-03-11	2017-06-23	百时美施贵宝公司	作为钾离子通道抑制剂的吡咯并三嗪类化合物
WO2015081783A1 (zh) *	2013-12-06	2015-06-11	江苏奥赛康药业股份有限公司	吡咯并[2,1-f][1,2,4]三嗪类衍生物及其制备方法和用途
CN111533708B (zh) *	2020-06-12	2021-03-16	上海馨远医药科技有限公司	一种手性n-叔丁氧羰基吗啉-3-羧酸的制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4908056A (en) *	1986-04-25	1990-03-13	E. I. Du Pont De Nemours And Company	Heterocyclic acyl sulfonamides
EP0778277B1 (en)	1995-12-08	2003-06-25	Pfizer Inc.	Substituted heterocyclic derivatives as CRF antagonists
JP3621706B2 (ja)	1996-08-28	2005-02-16	ファイザー・インク	置換された６，５―ヘテロ―二環式誘導体
KR100666514B1 (ko) *	1999-05-21	2007-02-28	브리스톨-마이어즈 스퀴브 컴페니	키나제의 피롤로트리아진 저해제
US6787545B1 (en)	1999-08-23	2004-09-07	Shiongi & Co., Ltd.	Pyrrolotriazine derivatives having spla2-inhibitory activities
GEP20063915B (en) *	2000-11-17	2006-09-11	Bristol Myers Squibb Co	PYRROLOTRIAZINE COMPOUNDS USEFUL AS KINASE INHIBITORS AND USE THEREOF FOR TREATING p38 KINASE-ASSOCIATED CONDITIONS
US6867300B2 (en)	2000-11-17	2005-03-15	Bristol-Myers Squibb Company	Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors
TW200300350A (en) *	2001-11-14	2003-06-01	Bristol Myers Squibb Co	C-5 modified indazolylpyrrolotriazines
TW200306841A (en)	2002-04-23	2003-12-01	Bristol Myers Squibb Co	Aryl ketone pyrrolo-triazine compounds useful as kinase inhibitors
AU2003231034B2 (en)	2002-04-23	2009-03-05	Bristol-Myers Squibb Company	Pyrrolo-triazine aniline compounds useful as kinase inhibitors
TW200400034A (en)	2002-05-20	2004-01-01	Bristol Myers Squibb Co	Pyrazolo-pyrimidine aniline compounds useful as kinase inhibitors
TWI329112B (en)	2002-07-19	2010-08-21	Bristol Myers Squibb Co	Novel inhibitors of kinases
TW200420565A (en) *	2002-12-13	2004-10-16	Bristol Myers Squibb Co	C-6 modified indazolylpyrrolotriazines
US7102001B2 (en) *	2003-12-12	2006-09-05	Bristol-Myers Squibb Company	Process for preparing pyrrolotriazine

2003
- 2003-12-08 TW TW092134601A patent/TW200420565A/zh unknown
- 2003-12-12 AU AU2003300877A patent/AU2003300877B2/en not_active Ceased
- 2003-12-12 BR BR0316755-0A patent/BR0316755A/pt not_active IP Right Cessation
- 2003-12-12 EP EP03813396A patent/EP1569937B1/en not_active Expired - Lifetime
- 2003-12-12 WO PCT/US2003/039542 patent/WO2004054514A2/en not_active Ceased
- 2003-12-12 JP JP2004560804A patent/JP4511367B2/ja not_active Expired - Fee Related
- 2003-12-12 RS YUP-2005/0441A patent/RS20050441A/sr unknown
- 2003-12-12 AT AT03813396T patent/ATE534648T1/de active
- 2003-12-12 PL PL377517A patent/PL377517A1/pl not_active Application Discontinuation
- 2003-12-12 UA UAA200506891A patent/UA80591C2/uk unknown
- 2003-12-12 RU RU2005120650/04A patent/RU2356903C2/ru not_active IP Right Cessation
- 2003-12-12 HR HR20050535A patent/HRP20050535A2/hr not_active Application Discontinuation
- 2003-12-12 KR KR1020057010549A patent/KR101073801B1/ko not_active Expired - Fee Related
- 2003-12-12 CN CNA200380105906XA patent/CN1726216A/zh active Pending
- 2003-12-12 ES ES03813396T patent/ES2374393T3/es not_active Expired - Lifetime
- 2003-12-12 CA CA002509650A patent/CA2509650C/en not_active Expired - Fee Related
- 2003-12-12 CN CN200910246410A patent/CN101723948A/zh active Pending
- 2003-12-12 DK DK03813396.3T patent/DK1569937T3/da active
- 2003-12-12 PE PE2003001275A patent/PE20040805A1/es not_active Application Discontinuation
- 2003-12-12 AR ARP030104592A patent/AR042450A1/es unknown
- 2003-12-12 PT PT03813396T patent/PT1569937E/pt unknown
- 2003-12-12 MX MXPA05006164A patent/MXPA05006164A/es active IP Right Grant
- 2003-12-12 NZ NZ540338A patent/NZ540338A/en not_active IP Right Cessation
- 2003-12-15 US US10/736,476 patent/US6916815B2/en not_active Expired - Fee Related
2005
- 2005-06-01 ZA ZA200504507A patent/ZA200504507B/en unknown
- 2005-06-02 US US11/143,279 patent/US7148220B2/en not_active Expired - Fee Related
- 2005-06-07 NO NO20052733A patent/NO20052733L/no not_active Application Discontinuation
- 2005-06-10 IS IS7890A patent/IS7890A/is unknown
- 2005-06-13 CO CO05057043A patent/CO5570660A2/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
UA80591C2 (en)	2007-10-10
CA2509650C (en)	2007-10-30
US7148220B2 (en)	2006-12-12
CO5570660A2 (es)	2005-10-31
IS7890A (is)	2005-06-10
CN1726216A (zh)	2006-01-25
CA2509650A1 (en)	2004-07-01
JP4511367B2 (ja)	2010-07-28
HRP20050535A2 (en)	2005-12-31
EP1569937A2 (en)	2005-09-07
PE20040805A1 (es)	2004-11-20
ZA200504507B (en)	2006-08-30
NO20052733L (no)	2005-07-07
US6916815B2 (en)	2005-07-12
KR20050084242A (ko)	2005-08-26
AR042450A1 (es)	2005-06-22
US20050222153A1 (en)	2005-10-06
US20040142931A1 (en)	2004-07-22
EP1569937B1 (en)	2011-11-23
PL377517A1 (pl)	2006-02-06
AU2003300877A1 (en)	2004-07-09
BR0316755A (pt)	2005-10-25
MXPA05006164A (es)	2005-08-26
AU2003300877B2 (en)	2010-02-18
EP1569937A4 (en)	2007-08-08
RU2356903C2 (ru)	2009-05-27
TW200420565A (en)	2004-10-16
WO2004054514A2 (en)	2004-07-01
WO2004054514A3 (en)	2004-10-07
RU2005120650A (ru)	2006-01-20
NZ540338A (en)	2008-05-30
ES2374393T3 (es)	2012-02-16
KR101073801B1 (ko)	2011-10-13
RS20050441A (sr)	2007-04-10
ATE534648T1 (de)	2011-12-15
PT1569937E (pt)	2012-01-04
DK1569937T3 (da)	2012-01-02
JP2006509826A (ja)	2006-03-23
CN101723948A (zh)	2010-06-09

Publication	Publication Date	Title
DK1569937T3 (da)	2012-01-02	C-6 modificerede indazolylpyrrolotriaziner
ATE457980T1 (de)	2010-03-15	Aryloxime
ATE427876T1 (de)	2009-04-15	Luftkissenboot
ATE318817T1 (de)	2006-03-15	Aza-arylpiperazine
DE50212360D1 (de)	2008-07-24	Anfahrhilfesteuerungsvorrichtung
DE50212349D1 (de)	2008-07-17	Hirurgie
NO20044046L (no)	2004-11-15	Substituerte hydroksyetylaminer
DE50301200D1 (de)	2005-10-20	Wischblatt
ATE349458T1 (de)	2007-01-15	Etonogestrelester
ATE496887T1 (de)	2011-02-15	Substituierte 5-aminomethyl-1h-pyrrol-2-carbons ureamide
ATA1572002A (de)	2003-06-15	Managementspleisskassette
DE50302660D1 (de)	2006-05-11	Stopfmachine
DE50301960D1 (de)	2006-01-26	Hydrolager
DE50301464D1 (de)	2005-12-01	Schraubensicherung
BR0311793B1 (pt)	2013-12-31	Projétil de neblina
ATA4142004A (de)	2005-12-15	Trägerverbau
ATE469773T1 (de)	2010-06-15	Zugöse
DE50303317D1 (de)	2006-06-14	Einschub-leistungsschalter
DE50307628D1 (de)	2007-08-16	Getraenkehalter
ATA19152002A (de)	2004-11-15	Hubkupplung
DE50209283D1 (de)	2007-03-08	Tropfbewässerungsrohr
ATE396192T1 (de)	2008-06-15	N-sulfonylaminothiazole
DE50306228D1 (de)	2007-02-15	Substituierte benzdioxepine
DE50300322D1 (de)	2005-03-31	Zylinderkopfdichtung
DE10244834B8 (de)	2005-01-13	Suszeptometer

Legal Events

Date	Code	Title	Description
2008-07-21	FC2A	Withdrawal, rejection or dismissal of laid open patent application